Literature DB >> 23759245

High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.

Qitian Mu1, Yungui Wang, Bing Chen, Wenbin Qian, Haitao Meng, Hongyan Tong, Feifei Chen, Qiuling Ma, Wanmao Ni, Saijuan Chen, Jie Jin.   

Abstract

Musashi-2 (MSI2) expression of 116 adult B-cells acute lymphoblastic leukemia (B-ALL) patients was measured by real-time PCR. Kaplan-Meier analysis showed that patients with high MSI2 expression had inferior overall survival (OS) (P=0.004), event free survival (EFS) (P=0.001) and relapse free survival (RFS) (P=0.018) in BCR-ABL-negative B-ALL. Multivariate models revealed that, besides WBC more than 30×10(9)/L and IK6 variant of IKZF1, high MSI2 expression was also an independent prognostic factor for adult BCR-ABL-negative B-ALL. Our data suggest that high MSI2 expression could indicate poor prognosis and facilitate risk and treatment stratification in adult BCR-ABL-negative B-ALL.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759245     DOI: 10.1016/j.leukres.2013.05.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

1.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Authors:  Sun-Mi Park; Mithat Gönen; Ly Vu; Gerard Minuesa; Patrick Tivnan; Trevor S Barlowe; James Taggart; Yuheng Lu; Raquel P Deering; Nir Hacohen; Maria E Figueroa; Elisabeth Paietta; Hugo F Fernandez; Martin S Tallman; Ari Melnick; Ross Levine; Christina Leslie; Christopher J Lengner; Michael G Kharas
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

2.  Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.

Authors:  Chenlu Yang; Weijing Zhang; Longwang Wang; Gallina Kazobinka; Xiaomin Han; Bin Li; Teng Hou
Journal:  Lab Invest       Date:  2016-06-20       Impact factor: 5.662

3.  ETS-related gene is a novel prognostic factor in childhood acute lymphoblastic leukemia.

Authors:  Hai-Zhao Zhao; Ming Jia; Ze-Bin Luo; Xiao-Jun Xu; Si-Si Li; Jing-Ying Zhang; Xiao-Ping Guo; Yong-Min Tang
Journal:  Oncol Lett       Date:  2016-11-18       Impact factor: 2.967

4.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

5.  A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation.

Authors:  Reza Saleki; Todd Christensen; Weihua Liu; Xiaowen Wang; Qing C Chen; Matthew Aakre; Nuno M V Gomes; Borislav A Alexiev; Joseph Schappert; Maria R Baer; Ying S Zou
Journal:  Leuk Lymphoma       Date:  2014-08-20

6.  A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.

Authors:  Gerard Minuesa; Christophe Antczak; David Shum; Constantin Radu; Bhavneet Bhinder; Yueming Li; Hakim Djaballah; Michael G Kharas
Journal:  Comb Chem High Throughput Screen       Date:  2014       Impact factor: 1.339

Review 7.  RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family.

Authors:  Jessie M Sutherland; Nicole A Siddall; Gary R Hime; Eileen A McLaughlin
Journal:  Asian J Androl       Date:  2015 Jul-Aug       Impact factor: 3.285

8.  Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.

Authors:  Yixiang Han; Aifang Ye; Yan Zhang; Zhimin Cai; Wei Wang; Lan Sun; Songfu Jiang; Jianbo Wu; Kang Yu; Shenghui Zhang
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  Blast crisis Ph+ chronic myeloid leukemia with NUP98/HOXA13 up-regulating MSI2.

Authors:  Danika Di Giacomo; Valentina Pierini; Gianluca Barba; Veronica Ceccarelli; Alba Vecchini; Cristina Mecucci
Journal:  Mol Cytogenet       Date:  2014-06-20       Impact factor: 2.009

Review 10.  Cancer epigenetics: Moving forward.

Authors:  Angela Nebbioso; Francesco Paolo Tambaro; Carmela Dell'Aversana; Lucia Altucci
Journal:  PLoS Genet       Date:  2018-06-07       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.